• Tue news: Obesity pill race heats up. Express Scripts sues FTC. More ESMO data. Kairos IPO. Daiichi-Merck guided-missile cancer drug. See more on our front page

Prothena leverages Walgreens’ capabilities to accelerate development of Alzheimer’s Drug

cafead

Administrator
Staff member
  • cafead   Apr 16, 2023 at 11:22: PM
via Prothena’s PRX012 received a Fast Track designation from the Food and Drug Administration last April and is undergoing single ascending dose and multiple ascending dose studies.

article source